Total Payments
$1,425
2024 Payments
$229.57
Companies
17
Transactions
34
Medicare Patients
1,411
Medicare Billing
$78,751
Payment Breakdown by Category
Food & Beverage$1,127 (79.1%)
Education$298.42 (20.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,127 | 31 | 79.1% |
| Education | $298.42 | 3 | 20.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Daiichi Sankyo Inc. | $304.29 | 5 | $0 (2024) |
| Gilead Sciences, Inc. | $230.40 | 2 | $0 (2024) |
| Seagen Inc. | $129.20 | 3 | $0 (2022) |
| Pharmacyclics LLC, An AbbVie Company | $128.65 | 5 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $121.46 | 2 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $115.20 | 1 | $0 (2023) |
| Lilly USA, LLC | $98.48 | 1 | $0 (2021) |
| Incyte Corporation | $53.66 | 3 | $0 (2022) |
| Blueprint Medicines Corporation | $39.67 | 1 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $37.97 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $229.57 | 6 | Gilead Sciences, Inc. ($119.70) |
| 2023 | $614.45 | 10 | Daiichi Sankyo Inc. ($276.78) |
| 2022 | $218.20 | 7 | Takeda Pharmaceuticals U.S.A., Inc. ($99.99) |
| 2021 | $363.18 | 11 | Seagen Inc. ($113.20) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/23/2024 | ABBVIE INC. | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $33.25 | General |
| Category: ONCOLOGY | ||||||
| 06/11/2024 | Janssen Scientific Affairs, LLC | TALVEY (Biological), TECVAYLI, DARZALEX | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Oncology | ||||||
| 06/06/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $119.70 | General |
| Category: ONC | ||||||
| 05/14/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: ONCOLOGY | ||||||
| 04/24/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $27.51 | General |
| Category: Iron Deficiency Anemia | ||||||
| 03/21/2024 | PFIZER INC. | ELREXFIO (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: ONCOLOGY | ||||||
| 12/19/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $29.06 | General |
| Category: Iron Deficiency Anemia | ||||||
| 12/13/2023 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: ONCOLOGY | ||||||
| 11/16/2023 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $110.70 | General |
| Category: ONC | ||||||
| 10/18/2023 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $115.20 | General |
| Category: Oncology | ||||||
| 10/17/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $29.51 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: Iron Deficiency Anemia | ||||||
| 09/06/2023 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | In-kind items and services | $39.67 | General |
| Category: Oncology / Rare Diseases | ||||||
| 09/06/2023 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Oncology | ||||||
| 05/16/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $123.25 | General |
| Category: ONCOLOGY | ||||||
| 04/25/2023 | Daiichi Sankyo Inc. | — | Food and Beverage | In-kind items and services | $96.17 | General |
| 10/20/2022 | Incyte Corporation | JAKAFI (Drug), MONJUVI, PEMAZYRE | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Hematology/Oncology | ||||||
| 10/19/2022 | Incyte Corporation | JAKAFI (Drug), MONJUVI | Food and Beverage | Cash or cash equivalent | $12.54 | General |
| Category: Hematology/Oncology | ||||||
| 07/27/2022 | Pharmacyclics LLC, an AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: ONCOLOGY | ||||||
| 05/12/2022 | Astellas Pharma US Inc | PADCEV (Drug) | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: Oncology | ||||||
| 05/09/2022 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Oncology | ||||||
| 04/21/2022 | Takeda Pharmaceuticals U.S.A., Inc. | — | Education | In-kind items and services | $99.99 | General |
| 04/09/2022 | Pharmacyclics LLC, an AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: ONCOLOGY | ||||||
| 11/11/2021 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: ONCOLOGY | ||||||
| 10/18/2021 | Genentech USA, Inc. | GAZYVA (Biological), VENCLEXTA | Food and Beverage | In-kind items and services | $7.91 | General |
| Category: BioOncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 137 | 170 | $38,958 | $9,005 |
| 2022 | 17 | 521 | 6,455 | $117,117 | $26,381 |
| 2021 | 13 | 479 | 814 | $132,453 | $26,987 |
| 2020 | 6 | 274 | 401 | $81,181 | $16,377 |
Total Patients
1,411
Total Services
7,840
Medicare Billing
$78,751
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 59 | 82 | $30,914 | $6,768 | 21.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 13 | $6,903 | $1,578 | 22.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 23 | 26 | $546.00 | $269.10 | 49.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 23 | 26 | $390.00 | $197.86 | 50.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 20 | 23 | $205.25 | $192.78 | 93.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 112 | 181 | $68,201 | $14,446 | 21.2% |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 2022 | 11 | 5,610 | $12,623 | $3,570 | 28.3% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 21 | 33 | $16,335 | $3,115 | 19.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 72 | 95 | $1,995 | $989.05 | 49.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 18 | $4,824 | $986.52 | 20.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 77 | 98 | $1,470 | $750.26 | 51.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 14 | 15 | $3,810 | $700.08 | 18.4% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2022 | 18 | 44 | $2,772 | $482.80 | 17.4% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 11 | 14 | $1,512 | $319.82 | 21.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 78 | 98 | $833.00 | $289.89 | 34.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 20 | 24 | $1,728 | $234.92 | 13.6% |
| 82728 | Ferritin (blood protein) level | Office | 2022 | 11 | 11 | $286.00 | $148.02 | 51.8% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2022 | 12 | 17 | $212.50 | $108.78 | 51.2% |
| 83550 | Iron binding capacity | Office | 2022 | 11 | 11 | $187.00 | $94.93 | 50.8% |
| 83540 | Iron level | Office | 2022 | 11 | 11 | $137.50 | $70.28 | 51.1% |
| 85007 | Microscopic examination for white blood cells with manual cell count | Office | 2022 | 12 | 16 | $112.00 | $60.12 | 53.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 12 | 159 | $79.50 | $15.15 | 19.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 124 | 201 | $90,858 | $17,500 | 19.3% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 25 | 27 | $13,770 | $2,734 | 19.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 17 | 17 | $10,710 | $2,116 | 19.8% |
About Julie Hazelton, NP
Julie Hazelton, NP is a Family healthcare provider based in Kennebunk, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164584652.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Julie Hazelton, NP has received a total of $1,425 in payments from pharmaceutical and medical device companies, with $229.57 received in 2024. These payments were reported across 34 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,127).
As a Medicare-enrolled provider, Hazelton has provided services to 1,411 Medicare beneficiaries, totaling 7,840 services with total Medicare billing of $78,751. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Nurse Practitioner, Family
- Location Kennebunk, ME
- Active Since 12/14/2006
- Last Updated 11/06/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1164584652
Products in Payments
- Trodelvy (Drug) $230.40
- IMBRUVICA (Drug) $128.65
- Enhertu (Drug) $123.25
- ENHERTU (Biological) $115.20
- VERZENIO (Drug) $98.48
- INJECTAFER (Drug) $84.87
- AYVAKIT (Drug) $39.67
- JAKAFI (Drug) $37.54
- EPKINLY (Drug) $33.25
- PADCEV (Drug) $31.03
- ADCETRIS (Biological) $29.25
- NINLARO (Drug) $21.47
- LUMAKRAS (Drug) $21.12
- Tepmetko (Drug) $19.69
- TALVEY (Biological) $18.03
- ELREXFIO (Drug) $16.38
- MONJUVI (Drug) $16.12
- IBRANCE (Drug) $14.70
- GAZYVA (Biological) $12.22
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Kennebunk
Patti Duprey, Arnp, ARNP
Family — Payments: $32,777
Family $32,777
Ms. Emily O'connell, Np, NP
Family — Payments: $54.40
Family $54.40
Kristy Laroche, Aprn-Cnp, APRN-CNP
Family — Payments: $22.34
Family $22.34
Mrs. Gloria Oppen, Np, NP
Family
Family
Deborah Freeman, Rn Fnp, RN FNP
Family
Family
Kristen Morrisroe, Fnp, FNP
Family
Family